Projects IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities. Breadcrumb Home Keywords Research group - Any -Cell Virology and Immunology (VIC)Immunology (IGG)Microbial Genomics (GEM)Neoantigens and Vaccines against Cancer (NeoVaCan)Pathogen Immunity, Signalling and Therapeutic Applications (PISTA)Retrovirology and Clinical Studies (GREC)T-cell Immunology and Vaccines (TIV)Tissue Virology (VITI)Translational Research in Immunology and Ageing (TRIA)Viral Immune Evasion and Vaccines (VIRIEVAC)Virus-Host Interactions (ViHIT) Researcher - Any -Aleix Elizalde TorrentAlejandro Riquelme GrauAlessandra BorgognoneAlex Olvera van der StoepAmaya Blanco PereraAna GervassiAnaí Villanueva DelgadoAnna Pineda MicolaAnna Pons GrifolsArnau Creus OrodeaBeatriz Mothe PujadasBenjamin TrinitéBonaventura Clotet SalaCarla Rovirosa MartíCarla Sánchez RuizCarmen Aguilar GurrieriCecilia Cabrera NavarroChristian BranderCristina Benitez RodríguezCristina Hurtado TripianaCristina Mesa RealCristina Peligero CruzCristina Ramírez SotoCristina Saiz MasvidalDàlia Raïch ReguéEdurne García VidalEdwards Pradenas SaavedraElena Lapaz LorenzoElisabet Fernández RosasElisabet García RodríguezElisa Molina MolinaEloi Franco Trepat Ester Aparicio PratsEster Ballana GuixEudald Felip FalgàsEudald Vehí PiquéEulalia Grau SegúEva Armendariz BurgoaEva Riveira MuñozFernando Laguía NuedaFerran Abancó i EspugaFrancesc Català MollFrancesc Cunyat ViaplanaFrancisco M. Muñoz LópezGabriel Felipe Rodríguez LozanoGemma Montagut PinoGerard Campos GonzalezGooya BanaeiGustavo Rodríguez EstebanIgnasi Calba IñiguezIgor Moraes CardosoIrene González NavarroIrene Silva RuizIris TeubelItziar Erkizia JauregiJacopo Faranda CordellaJakub ChojnackiJavier Martínez-PicadoJeremy Tessier Joan Pagès OliverasJon Izquierdo PujolJorge Carrillo MolinaJosé Luis Pérez GuillamónJudith Dalmau MorenoJulia García PradoJulià Blanco ArbuésJulián Eslava CampoJúlia Albó DelgadoLaia Bernad RosaLaia Vives AdriánLaura Ferrer CendraLidia Garrido SanzLidia Ruiz TabuencaLourdes Grau ParéLucía Gómez EspadaMacedonia Trigueros PeñaMarc Noguera i JulianMaria Casadellà FontdevilaMaria Nevot BanúsMaria Salgado BernalMarina Martinez VelascoMarina Matilla MartínezMarina Pino CebriánMariona Parera SallentMarissa Flores SantamaríaMarta Massanella LunaMarta Ruiz RiolMaría Lázaro DíezMireia Martínez GameroMª Carmen García GuerreroMª Carmen Puertas CastroMª Luisa Rodríguez de la ConcepciónNatàlia Marrugat VilaNel Marín SánchezNuria Izquierdo UserosNúria de la Iglesia ZaragozaOriol Careta BorràsPatricia Piñol JuradoPatricia Resa InfantePenélope Riquelme NevadoRafaela Ayen AparicioRaúl Pérez CaballeroRita Casas CostaRoger ParedesRosina Malagrida EscalasRuth Peña PoderósRytis BoreikaSamandhy Cedeño BriceñoSandra Franco CireraSantiago Cavero MartínezSara Cabrero de las HerasSara Morón LópezSilvia Marfil VerchiliSonia Bange SinghSonia Villanueva HernándezSusana Esteban RayaSílvia Ribó GenéTeresa Puig OlivaTetyana PidkovaThuong NguyenTuixent Escribà BelValentina Triviño VenceVíctor Urrea GalesÀlex Pérez Hita From date To date Incorporation of a new subject and new groups to the Consortium of the Centro de Investigación Biomédica en Red M.P. (CIBER) Project status Ongoing Start/End 2022 Principal investigator Julia García Prado Javier Martínez-Picado Participating entities IrsiCaixa, IGTP Financing entity ISCIII RBD Dimer recombinant protein vaccine against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Ruiz Riol Julià Blanco Arbués Christian Brander Jorge Carrillo Molina Samandhy Cedeño Briceño Julia García Prado Nuria Izquierdo Useros Tuixent Escribà Bel Eulalia Grau Segú Beatriz Mothe Pujadas External researchers Èlia Torroella Strategic lines Cancer Emerging infectious diseases Financing entity European Commission Codi: 101046118 DURVAST: A phase II exploratory study of durvalumab (MEDI4736) in HIV-1 patients with advanced solid tumors Project status Ongoing Start/End 2017 / 2019 Principal investigator Javier Martínez-Picado Participating entities Spanish Lung Cancer Cooperative Group & IrsiCaixa AIDS Research Institute. Financing entity AstraZeneca Translational study of Inhibitory Receptors in HIV-1 infection: Identification of novel immunotherapeutic targets to reverse T-cell immune exhaustion Project status Ongoing Start/End 2018 / 2020 Principal investigator Julia García Prado Participating entities Institut de Recerca de la Sida IrsiCaixa Financing entity Ministry of the Economy, Industry and Competitiveness - Carlos III Health Institute (ISCIII) – FEDER. PI17/00164 Preclinical evaluation of immunoregulatory molecules in combination with latency reactivators for the development of new HIV-1 erradication strategies Project status Ongoing Start/End 2015 / 2018 Principal investigator Julia García Prado Financing entity Ministry of the Economy and Competitiveness - Carlos III Health Institute (ISCIII) - FEDER. PI14/01058 LKR155762 Combine use of vaccines an immune check blockers to boost CTL activity against the reservoir Project status Ongoing Start/End 2017 / 2019 Principal investigator Julia García Prado Financing entity MSD Glicoingeniería de nanovehículos para eliminar los reservorios virales; saf2017-91767-exp Project status Ongoing Start/End Principal investigator Nuria Izquierdo Useros Participating entities Irsicaixa, ICN2, UPV-CSIC Financing entity MINECO Connecting innate and adaptive immunity via TRIM5 proteins for cellular resistance to HIV Project status Ongoing Start/End Principal investigator Julia García Prado Financing entity Beatriu de Pinós post-doctoral fellowship, AGAUR CELLRE - TRIM5-based gene therapy approaches for inducible cellular resistance to HIV-1 Project status Ongoing Start/End 2018 / 2023 Principal investigator Julia García Prado Financing entity Grifols RECOVIR - Breaking the Immune Exhaustion Barrier to Recover Antiviral Immunity for the HIV-1 Cure Project status Ongoing Start/End 2018 / 2023 Principal investigator Julia García Prado Financing entity Grifols Pagination 1 Page 2 Next Last
Incorporation of a new subject and new groups to the Consortium of the Centro de Investigación Biomédica en Red M.P. (CIBER) Project status Ongoing Start/End 2022 Principal investigator Julia García Prado Javier Martínez-Picado Participating entities IrsiCaixa, IGTP Financing entity ISCIII
RBD Dimer recombinant protein vaccine against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Ruiz Riol Julià Blanco Arbués Christian Brander Jorge Carrillo Molina Samandhy Cedeño Briceño Julia García Prado Nuria Izquierdo Useros Tuixent Escribà Bel Eulalia Grau Segú Beatriz Mothe Pujadas External researchers Èlia Torroella Strategic lines Cancer Emerging infectious diseases Financing entity European Commission Codi: 101046118
DURVAST: A phase II exploratory study of durvalumab (MEDI4736) in HIV-1 patients with advanced solid tumors Project status Ongoing Start/End 2017 / 2019 Principal investigator Javier Martínez-Picado Participating entities Spanish Lung Cancer Cooperative Group & IrsiCaixa AIDS Research Institute. Financing entity AstraZeneca
Translational study of Inhibitory Receptors in HIV-1 infection: Identification of novel immunotherapeutic targets to reverse T-cell immune exhaustion Project status Ongoing Start/End 2018 / 2020 Principal investigator Julia García Prado Participating entities Institut de Recerca de la Sida IrsiCaixa Financing entity Ministry of the Economy, Industry and Competitiveness - Carlos III Health Institute (ISCIII) – FEDER. PI17/00164
Preclinical evaluation of immunoregulatory molecules in combination with latency reactivators for the development of new HIV-1 erradication strategies Project status Ongoing Start/End 2015 / 2018 Principal investigator Julia García Prado Financing entity Ministry of the Economy and Competitiveness - Carlos III Health Institute (ISCIII) - FEDER. PI14/01058
LKR155762 Combine use of vaccines an immune check blockers to boost CTL activity against the reservoir Project status Ongoing Start/End 2017 / 2019 Principal investigator Julia García Prado Financing entity MSD
Glicoingeniería de nanovehículos para eliminar los reservorios virales; saf2017-91767-exp Project status Ongoing Start/End Principal investigator Nuria Izquierdo Useros Participating entities Irsicaixa, ICN2, UPV-CSIC Financing entity MINECO
Connecting innate and adaptive immunity via TRIM5 proteins for cellular resistance to HIV Project status Ongoing Start/End Principal investigator Julia García Prado Financing entity Beatriu de Pinós post-doctoral fellowship, AGAUR
CELLRE - TRIM5-based gene therapy approaches for inducible cellular resistance to HIV-1 Project status Ongoing Start/End 2018 / 2023 Principal investigator Julia García Prado Financing entity Grifols
RECOVIR - Breaking the Immune Exhaustion Barrier to Recover Antiviral Immunity for the HIV-1 Cure Project status Ongoing Start/End 2018 / 2023 Principal investigator Julia García Prado Financing entity Grifols